Literature DB >> 14060169

MAST CELL DISEASE.

S RABINOVICH, D C LEY.   

Abstract

Keywords:  ANTIHISTAMINICS; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; ELECTROENCEPHALOGRAPHY; MAST CELLS; PATHOLOGY; RADIOGRAPHY; URTICARIA; URTICARIA PIGMENTOSA

Mesh：

Substances：

Year:  1963        PMID： 14060169      PMCID： PMC1922011     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Urticaria pigmentosa and generalized mastocytosis. Polymyxin Btreatment.

Authors:  G ASBOE-HANSEN
Journal:  Arch Dermatol       Date:  1961-06

2.  Urticaria pigmentosa as a systemic disease.

Authors:  C BERLIN
Journal:  AMA Arch Derm       Date:  1955-06

3.  The mast cells and mastocytosis: with special reference to bone changes.

Authors:  F SAGHER; Z EVEN-PAZ
Journal:  S Afr Med J       Date:  1961-06-10

4.  Mast cell leukemia? Malignant mastocytosis with leukemia-like manifestations.

Authors:  P EFRATI; A KLAJMAN; H SPITZ
Journal:  Blood       Date:  1957-10       Impact factor: 22.113

5.  5-Hydroxytryptamine in mast cells.

Authors:  E P BENDITT; R L WONG; M ARASE; E ROEPER
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

6.  Urticaria pigmentosa; mastocytosis; a consideration of various manifestations.

Authors:  W R NICKEL
Journal:  AMA Arch Derm       Date:  1957-10

7.  Bone lesions in urticaria pigmentosa.

Authors:  F SAGHER; S SCHORR
Journal:  J Invest Dermatol       Date:  1956-06       Impact factor: 8.551

8.  Urticaria pigmentosa treated with desoxycorticosterone.

Authors:  F URBACH; C JACOBSON; W BELL
Journal:  AMA Arch Derm Syphilol       Date:  1954-11

9.  The origin in synovial mucin; Ehrlich's mast cell, a secretory element of the connective tissue.

Authors:  G ASBOE-HANSEN
Journal:  Ann Rheum Dis       Date:  1950-06       Impact factor: 19.103
  9 in total
  1 in total

1.  Chronic urticaria and angioedema.

Authors:  J H Toogood
Journal:  Can Fam Physician       Date:  1967-07       Impact factor: 3.275
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.